Rachna Shroff, MD, MS, University of Arizona College of Medicine, Tucson, AZ, provides an overview of her highlights from the American Society of Clinical Oncology (ASCO) 2023 Gastrointestinal Cancers (GI) Symposium, including results from the SPOTLIGHT trial (NCT03504397) in patients with advanced gastric or gastroesophageal junction (GEJ) adenocarcinoma, as well as NAPOLI-3 (NCT04083235) trial in patients with metastatic pancreatic ductal adenocarcinoma (mPDAC). Additional highlights include findings from the SWOG 1815 trial (NCT03768414) in patients with biliary tract cancers, as well as advances in the role of ctDNA in colorectal cancer. This interview took place at the ASCO 2023 GI Symposium in San Francisco, CA.
These works are owned by Magdalen Medical Publishing (MMP) and are protected by copyright laws and treaties around the world. All rights are reserved.